Comstock Act Revival Threatens Abortion Pill Access Nationwide
The Trump administration is preparing to use the Comstock Act of 1873 to ban mailing abortion pills, a move that would effectively end medication abortion access across the country.
The Slate article warns that a key legal lever—the Comstock Act—is being readied by the Trump administration to restrict abortion pill access without new legislation. Todd Blanche, the Deputy Attorney General, is reportedly exploring enforcement of this 19th-century anti-vice law to block the mailing of mifepristone and misoprostol. This represents a concrete federal action: a Department of Justice memo or guidance would trigger nationwide consequences, potentially halting the primary method of abortion care in the U.S. since 2023.
The harm is acute: medication abortion accounts for over 60% of all abortions, and the Comstock Act's broad language could be interpreted to ban shipment of any drug or device used for abortion, not just pills. Clinics, mail-order pharmacies, and even patients receiving pills by mail would face criminal penalties. The administration's move targets a specific regulatory mechanism—the U.S. Postal Service or FDA enforcement—to circumvent Congress and the courts, leveraging existing statutes to achieve a near-total abortion ban.
A concrete progressive alternative requires Congress to repeal the Comstock Act's abortion-related provisions (H.R. 1 or the Women's Health Protection Act) and for the FDA to maintain its risk-evaluation and mitigation strategy (REMS) for mifepristone, which currently allows telehealth prescribing and mail-order dispensing. States could also sue to block enforcement, arguing the act conflicts with FDA authority and interstate commerce protections.
The humanitarian alternative
Congress should pass the Women's Health Protection Act (WHPA), which would codify the right to abortion access and explicitly preempt the Comstock Act's application to reproductive healthcare. Pending that, the FDA should continue its REMS program allowing mail-order pharmacies to dispense mifepristone under telehealth supervision, ensuring safe and equitable access. States with shield laws can protect clinicians and patients from federal prosecution by refusing to cooperate with Comstock Act enforcement.
Falsifiable predictions
What this entry claims will happen, and what data would prove it wrong. The Reckoner revisits these against current reality.
- The DOJ will issue a formal opinion or guidance interpreting the Comstock Act to prohibit mailing of abortion pills within the next 6 months.
- Major pharmacy chains (CVS, Walgreens) will cease dispensing abortion pills by mail within 90 days of such guidance.
Original source — excerpted
news We’re About to Reach a Dangerous Fork in the Road for Abortion Rights"Sign up for Executive Dysfunction, a newsletter that highlights one under-the-radar story each week about how Trump is changing the law—or how the law is push..."